Posts by Sandra Ansanay-Alex
CHF 1 billion for Vaud-based start-ups
2021 was a record fundraising year for Swiss startups, according to the Swiss Venture Capital Report 2022. The covid 19 pandemic did not slow down investments in Switzerland. And companies in the canton of Vaud have been particularly fortunate. Vaud’s young tech firms pulled in CHF 604.6 million in venture capital. An additional CHF…
Read MoreLa Source Launches H4
La Source opens an innovation platform dedicated to care and health in Vaud (Switzerland). The H4 “Hands-on Human Health Hub” was created to help start-ups in the life sciences sector overcome their early-stage difficulties. The project represents an investment of CHF 3 million over 5 years. Half will be financed by the State of…
Read MoreMerck acquires Geneva-based biopharmaceutical company Chord Therapeutics
Merck invests into Cadribine to try to cure rare neuroinflammatory diseases Chord Therapeutics (Chord), a clinical-stage biopharmaceutical company developing drugs for rare neuroinflammatory diseases, announced on 20 December 2021, that it has been acquired by the leading science and technology company Merck. The strategic acquisition enables Merck to expand its neurology pipeline to develop…
Read More